BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26799199)

  • 1. Association Between the NFKB1-94ins/del ATTG Polymorphism (rs28362491) and Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Chen QJ; Lai HM; Zhao L; Ma YT; Li XM; Zhai H; Zhou Y; He CH; Chen BD; Liu F; Yang YN
    Genet Test Mol Biomarkers; 2016 Mar; 20(3):105-11. PubMed ID: 26799199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Variation in NFKB1 and NFKBIA and Susceptibility to Coronary Artery Disease in a Chinese Uygur Population.
    Lai HM; Li XM; Yang YN; Ma YT; Xu R; Pan S; Zhai H; Liu F; Chen BD; Zhao Q
    PLoS One; 2015; 10(6):e0129144. PubMed ID: 26075620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. -94 ATTG insertion/deletion polymorphism of the NFKB1 gene is associated with coronary artery disease in Han and Uygur women in China.
    Yang YN; Zhang JY; Ma YT; Xie X; Li XM; Liu F; Chen BD; Dong XH; Zheng YY; Pan S; Zhai H; Li DZ; Chen QJ
    Genet Test Mol Biomarkers; 2014 Jun; 18(6):430-8. PubMed ID: 24818816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC.
    Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S
    Cancer Biomark; 2016; 16(1):109-15. PubMed ID: 26835711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An updated meta-analysis of 37 case-control studies on the association between NFKB1 -94ins/del ATTG promoter polymorphism and cancer susceptibility.
    Luo YQ; Wang D; Gong T; Zhu J
    Oncotarget; 2016 Sep; 7(36):58659-58670. PubMed ID: 27463002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of inflammatory gene polymorphisms in left ventricular dysfunction (LVD) susceptibility in coronary artery disease (CAD) patients.
    Mishra A; Srivastava A; Mittal T; Garg N; Mittal B
    Cytokine; 2013 Mar; 61(3):856-61. PubMed ID: 23357300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of studies on the association between the NF-κB1-94ins/del ATTG promoter polymorphism and cancer.
    Nian X; Zhang W; Li L; Sun Y; Sun E; Han R
    Tumour Biol; 2014 Dec; 35(12):11921-31. PubMed ID: 25190017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFKB1 -94insertion/deletion ATTG polymorphism and cancer risk: Evidence from 50 case-control studies.
    Fu W; Zhuo ZJ; Chen YC; Zhu J; Zhao Z; Jia W; Hu JH; Fu K; Zhu SB; He J; Liu GC
    Oncotarget; 2017 Feb; 8(6):9806-9822. PubMed ID: 28039461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant association between rs28362491 polymorphism in NF-κB1 gene and coronary artery disease: a meta-analysis.
    Wang Y; Wu B; Zhang M; Miao H; Sun J
    BMC Cardiovasc Disord; 2020 Jun; 20(1):278. PubMed ID: 32513188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFKB1 promoter -94 insertion/deletion ATTG polymorphism (rs28362491) is associated with severity and disease progression of rheumatoid arthritis through interleukin-6 levels modulation in Egyptian patients.
    Elkhawaga SY; Gomaa MH; Elsayed MM; Ebeed AA
    Clin Rheumatol; 2021 Jul; 40(7):2927-2937. PubMed ID: 33459954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant DD genotype of NFKB1 gene is associated with the susceptibility and severity of coronary artery disease.
    Luo JY; Li XM; Zhou Y; Zhao Q; Chen BD; Liu F; Chen XC; Zheng H; Ma YT; Gao XM; Yang YN
    J Mol Cell Cardiol; 2017 Feb; 103():56-64. PubMed ID: 28088561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of NFKB1 -94ins/delATTG promoter polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.
    Zou YF; Wang F; Feng XL; Tao JH; Zhu JM; Pan FM; Su H
    Tissue Antigens; 2011 Jan; 77(1):9-17. PubMed ID: 21155719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer.
    Mohd Suzairi MS; Tan SC; Ahmad Aizat AA; Mohd Aminudin M; Siti Nurfatimah MS; Andee ZD; Ankathil R
    Cancer Epidemiol; 2013 Oct; 37(5):634-8. PubMed ID: 23806437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the NFKB1-94ins/del ATTG polymorphism and cancer risk: an updated meta-analysis.
    Duan W; Wang E; Zhang F; Wang T; You X; Qiao B
    Cancer Invest; 2014 Aug; 32(7):311-20. PubMed ID: 24827594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.
    Kurylowicz A; Hiromatsu Y; Jurecka-Lubieniecka B; Kula D; Kowalska M; Ichimura M; Koga H; Kaku H; Bar-Andziak E; Nauman J; Jarzab B; Ploski R; Bednarczuk T
    Genes Immun; 2007 Oct; 8(7):532-8. PubMed ID: 17690684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association and interaction of NFKB1 rs28362491 insertion/deletion ATTG polymorphism and PPP1R13L and CD3EAP related to lung cancer risk in a Chinese population.
    Yin J; Wang H; Vogel U; Wang C; Hou W; Ma Y
    Tumour Biol; 2016 Apr; 37(4):5467-73. PubMed ID: 26563375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population.
    Li P; Gu J; Yang X; Cai H; Tao J; Yang X; Lu Q; Wang Z; Yin C; Gu M
    PLoS One; 2013; 8(8):e71604. PubMed ID: 23977085
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Luo JY; Liu F; Fang BB; Tian T; Li YH; Zhang T; Li XM; Yang YN
    Oxid Med Cell Longev; 2022; 2022():9494926. PubMed ID: 36317060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between NFKB1 -94ins/del ATTG Promoter Polymorphism and Cancer Susceptibility: An Updated Meta-Analysis.
    Yang X; Li P; Tao J; Qin C; Cao Q; Gu J; Deng X; Wang J; Liu X; Wang Z; Wu B; Gu M; Lu Q; Yin C
    Int J Genomics; 2014; 2014():612972. PubMed ID: 24895544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal cell carcinoma.
    Cai H; Sun L; Cui L; Cao Q; Qin C; Zhang G; Mao X; Wang M; Zhang Z; Shao P; Yin C
    Urol Int; 2013; 91(2):206-12. PubMed ID: 23295440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.